Business Intelligence
Medical Technology Market Reports


Online business intelligence
for the medical technology
and biopharma industry,
supplied through Piribo

MTB Europe has teamed up with Piribo to offer our readers reports on the medical technology and biopharma industries by leading research companies.

Latest reports

Personalized Medicine. Scientific & Commercial Aspects 
The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics, pharmacoproteomics, and metabolomics. Biochip/microarray technologies are also important and bioinformatics is needed to analyze the immense amount of data generated by various technologies. more ...

Diabetes Drug Pipeline. Competitor Analysis
The Competitive Intelligence Report Diabetes Drug Pipeline as of November 2008 provides a competitor analysis in the development pipeline of novel antidiabetic treatment modalities for type 1 and 2 diabetes. The report includes an overview of the major marketed diabetes drugs and the respective markets sizes and describes the corporate diabetes drug product portfolios and R&D pipelines of more than 160 companies worldwide. November 2008

Biopharmaceutical Expression Systems and Genetic Engineering Technologies. Current and Future Manufacturing Platforms
In currently marketed products there has been little basic change in the technologies used for commercial-scale manufacture of biopharmaceutical products. New expression systems and recent improvements available for current systems have the potential to revolutionize the biopharmaceutical industry! Lower costs and efficiencies of newer expression systems are driving these changes. This book provides manufacturers with the information they need to make the shift to increased productivity. November 2008

Why do drugs fail?
This report analyses recent drug failure events and examines potential areas of remedy for regulators and companies. Greedy companies being economical with the truth? Overzealous regulators pursuing political agendas? Poorly designed or inconclusive clinical trials? What action can the industry and regulators take to improve their performance in this critical area? November 2008

Global Surgical Equipment Investment Opportunities, Analysis and Forecasts to 2012
This report is an essential source for key information and data relating to the Global surgical equipment market. The report provides overview of key trends, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the Global surgical equipment devices market. It also offers global and country level, detailed and comprehensive coverage of market revenue, volume, distribution and company share information. October 2008

Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2012
This report is an essential source for key information and data relating to the Global patient monitoring devices market. The report provides overview of key trends, drivers and restraints, future outlook, pipeline products, news, financial deals and competitive landscape and key developments in the Global patient monitoring devices market. It also offers global and country level, detailed and comprehensive coverage of market revenue, volume, distribution and company share information. October 2008

Western Europe, Healthcare Sector Pulse, April-June 2008
This Health Industry Insights update describes the Western European healthcare sector environment (payers and providers) in the second quarter of 2008 and discusses the macroeconomic and healthcare sector-specific trends. The main section looks at the major ICT contracts signed over the same period and other initiatives in place. Includes the NHS-Fujitsu case. September 2008

Nanobiotechnologies applications, markets and companies
The report starts with an introduction to various techniques and materials that are relevant to nanobiotechnology. It includes some of the physical forms of energy such as nanolasers. Some of the technologies are scaling down such as microfluidics to nanofluidic biochips and others are constructions from bottom up. Application in life sciences research, particularly at the cell level sets the stage for role of nanobiotechnology in healthcare in subsequent chapters. October 2008. Read more ...

Nanotechnology. Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics
Nanotechnologies have already attracted over $3bn of global government funding as part of efforts to enhance a range of disciplines including pharmaceuticals, drug delivery and healthcare monitoring. Advances in nanomaterials, nanostructures and nanosystems are expected to drive the value of the global nanotehnology market to over a trillion dollars by 2015, but many companies are remaining cautious, preferring to monitor developments in academia prior to making substantial investments. read more ...

Biomarkers: The Future of Next-Generation Drug R&D
This report analyzes the hot global market for biomarkers and related assays or tests used in drug R&D. The study reviews this dynamic market by looking at drug research and development spending trends, M&As, alliances, major diseases, applications, tools, technologies, products and services. This report suggests the future direction of the market for biomarkers and related '-omic' or pharmacogenomic (PGx) assays or tests used in the next-generation of drug R&D. This study sizes the world market and growth rate of biomarkers and assays for drug R&D spending to 2012. October 2008 Read more ...

RNA interference markets
Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the last decade. Some industry analysts predict that RNA interference (RNAi) may even surpass PCR as a top technology. Read more ...

Medical Nanotechnology Markets
Nanotechnology has reached critical mass. Nowhere is this more evident than in medicine. Rising medical costs, demands for less-invasive procedures and pressures for immediate feedback of medical conditions, all point to nanotechnology as offering a new approach in healthcare. According to US National Science Foundation estimates, by 2015 the annual global market for nano-related goods and services will top $1 trillion, thus making it one of the fastest-growing industries in history. Read more ...

Molecular Diagnostics. Technologies, Markets and Companies
This best-selling report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. Aimed at chief executives and chief development officers, it is the most comprehensive and up-to-date one-stop source of information on technical and commercial aspects of molecular diagnostics. It includes profiles of 250 companies more ...

Point of Care Diagnostic Testing. World Markets
The report describes the specific market segment of the in vitro diagnostics market called point-of-care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in near-patient environments like hospitals, clinics and doctor's offices. The study defines the dollar volume of sales, both worldwide and in the US, and analyzes the factors that influence the size and the growth of the market segments. more ... September 2008

Top 20 cancer therapy brands
Cancer therapy brand sales totaled over $30 billion in the seven major markets in 2007, growing by 20.1% since 2006. The high growth of this market makes it attractive to companies keen to emulate the blockbuster status achieved by several brands. However, with several impending patent expiries due, companies will need to work hard to maximize their return throughout the lifecycle of their brands. September 2008. Read more ...

Antidiabetics — Switching to new antidiabetics drives market growth
Datamonitor expects the antidiabetics market in the seven major markets is expected to grow from $18 billion in 2007 to $29 billion in 2017 at a rate of 5% CAGR. Significant unmet needs remain in diabetes fuelling a large pipeline. The epidemiological growth of the market, driven by the obesity epidemic and improved diagnosis rates, is further driving the market. September 2008. Read more ...

Health Care Equipment & Supplies in Germany
Publication Date: July 2008
Publisher: Datamonitor
Pages: 35
Price £180.00 approximately: $361 | €226

Health Care Equipment & Supplies in France
Publication Date: July 2008
Publisher: Datamonitor
Pages: 31
Price £180.00 approximately: $361 | €226

Health Care Equipment & Supplies in the United Kingdom
Publication Date: July 2008
Publisher: Datamonitor
Pages: 33
Price: £180.00 approximately: $361 | €226

McKesson Corporation Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo)...

IBA Health Limited Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...

TOSHIBA Medical Systems Corporation Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...

Smiths Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...

Philips Medical Systems Medical Equipment Company Share Analysis
Publication date: June 2008
Publisher: Global Markets Direct
Price £505.00 approximately: $1,000 | €642
More information (goes to Piribo) ...

France Diabetes Care Devices Investment Opportunities Analysis and Forecasts to 2012
Publication date: June 2008
Publisher Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information ...

Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information (goes to Piribo)...

Canada Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Price £1,515.00 approximately: $3,000 | €1,926
More information (goes to Piribo) ...

France Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012
Publication date: June 2008
Publisher: Global Markets Direct
Pages: 612
Price £1,515.00  approximately: $3,000 | €1,926
More information (goes to Piribo) ...

Companion Diagnostics Market
A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine
Publication date: June 2008
Publisher: Kalorama Information

GE Healthcare Product Pipeline Analysis
Publication date: May 2008
Publisher: Global Markets Direct

Germany Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
Publication date: May 2008
Publisher: Global Markets Direct

United States Medical Equipment Markets
Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012
Publication date: May 2008
Publisher: Global Markets Direct

Cell Therapy. Technologies, Markets and Companies
Publication Date: May 2008
Publisher: Jain PharmaBiotech

Major World Markets for Stents and The Economics of Drug-Eluting Technology
Publication date: May 2008
Publisher: Kalorama Information

Surgical Robot Market Shares, Market Strategies, and Market Forecasts, 2008-2014
Publication Date: January 2008
Publisher: Wintergreen Research

The European Hospital Register (CD-ROM)
Publication Date: March 2008
Publisher: Walnut Medical

Thousands of reports are available to buy and download.

See the broad categories:

 

To top